PL324904A1 - Application of fluconazole in carcinoma development inhibition - Google Patents

Application of fluconazole in carcinoma development inhibition

Info

Publication number
PL324904A1
PL324904A1 PL96324904A PL32490496A PL324904A1 PL 324904 A1 PL324904 A1 PL 324904A1 PL 96324904 A PL96324904 A PL 96324904A PL 32490496 A PL32490496 A PL 32490496A PL 324904 A1 PL324904 A1 PL 324904A1
Authority
PL
Poland
Prior art keywords
fluconazole
application
development inhibition
carcinoma development
carcinoma
Prior art date
Application number
PL96324904A
Other languages
English (en)
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/674,180 external-priority patent/US5908855A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PL324904A1 publication Critical patent/PL324904A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL96324904A 1995-08-04 1996-07-30 Application of fluconazole in carcinoma development inhibition PL324904A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US188995P 1995-08-04 1995-08-04
US08/674,180 US5908855A (en) 1996-07-16 1996-07-16 Compositions for treating viral infections
PCT/US1996/012474 WO1997005873A2 (en) 1995-08-04 1996-07-30 Use of fluconazole for inhibiting the growth of cancers

Publications (1)

Publication Number Publication Date
PL324904A1 true PL324904A1 (en) 1998-06-22

Family

ID=26669622

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96324904A PL324904A1 (en) 1995-08-04 1996-07-30 Application of fluconazole in carcinoma development inhibition

Country Status (18)

Country Link
EP (1) EP0841921A2 (xx)
JP (1) JPH11510187A (xx)
KR (1) KR19990036138A (xx)
CN (1) CN1195288A (xx)
AR (1) AR003175A1 (xx)
AU (1) AU711966B2 (xx)
BR (1) BR9609966A (xx)
CA (1) CA2229024A1 (xx)
CZ (1) CZ33798A3 (xx)
HU (1) HUP9903420A3 (xx)
IL (1) IL123095A0 (xx)
MX (1) MX9800998A (xx)
NO (1) NO980473L (xx)
NZ (2) NZ315184A (xx)
PL (1) PL324904A1 (xx)
SK (1) SK14198A3 (xx)
TR (2) TR199801739T2 (xx)
WO (1) WO1997005873A2 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
FR2742405B1 (fr) * 1995-12-13 1998-02-27 Cgea Comp Gen Entre Auto Unite motrice susceptible d'etre accouplee a une enceinte roulante et vehicule resultant
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
KR20010103655A (ko) * 1998-11-09 2001-11-23 케네쓰 제이. 울코트 키메라 항-ｃｄ２０항체를 이용한 순환성 종양세포와관련된 혈액학적 악성종양의 치료법
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US7004915B2 (en) * 2001-08-24 2006-02-28 Kci Licensing, Inc. Negative pressure assisted tissue treatment system
EP1895012A1 (en) 2006-08-30 2008-03-05 Universitätsklinikum Freiburg Method for inducing tumor apoptosis by increasing nitric oxide levels
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2019185521A1 (en) * 2018-03-26 2019-10-03 Westfälische Wilhelms-Universität Münster Ergosterol-biosynthesis inhibitor and influenza virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
BE1004029A6 (nl) * 1990-11-22 1992-09-08 Mol Omer De Farmaceutische samenstelling en farmaceutische set voor het behandelen van kanker.
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
TR199800270T1 (xx) 1998-05-21
AU711966B2 (en) 1999-10-28
CA2229024A1 (en) 1997-02-20
BR9609966A (pt) 1999-02-02
WO1997005873A3 (en) 1997-03-27
AR003175A1 (es) 1998-07-08
IL123095A0 (en) 1998-09-24
SK14198A3 (en) 1999-03-12
EP0841921A2 (en) 1998-05-20
AU6683396A (en) 1997-03-05
NZ503921A (en) 2002-03-01
NO980473L (no) 1998-04-03
NO980473D0 (no) 1998-02-03
MX9800998A (es) 1998-04-30
JPH11510187A (ja) 1999-09-07
KR19990036138A (ko) 1999-05-25
NZ315184A (en) 2000-05-26
HUP9903420A3 (en) 2001-12-28
TR199801739T2 (xx) 1998-12-21
WO1997005873A2 (en) 1997-02-20
CZ33798A3 (cs) 1998-06-17
CN1195288A (zh) 1998-10-07
HUP9903420A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
PL324904A1 (en) Application of fluconazole in carcinoma development inhibition
PL324905A1 (en) Application of griseofulvin in carcinoma development inhibition
EP1009415A4 (en) INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES
HUP9702436A3 (en) Use of aerogels in agriculture
PL323904A1 (en) C-4' modified inhibitors of andenosinic kinase
EP0794789A4 (en) PRENYL TRANSFERASE INHIBITORS
IL116485A0 (en) Monocyclic beta-lactams for use in inhibiting lrho pla2
PL324888A1 (en) Application of derivatives of 1,2,4-triazole in carcinoma development inhibition
PH31627A (en) Inhibition of silica precipitation.
GB2313841A8 (en) Hydrate inhibition
GB9526560D0 (en) Use of 2-Amino-Heterocycles
ZA9684B (en) Composition and use
EP0831920A4 (en) NOVEL CATHEPSIN AND METHODS AND COMPOSITIONS FOR INHIBITING CATHEPSIN
GB9512290D0 (en) Uses of polyhexanide
ZA964605B (en) Inhibition of exoprotein in absorbent article
EP0800649A4 (en) INHIBITION OF GLIA CELL PROLIFERATION
EG21286A (en) Blends of organosillane compounds and their use
EP0702080A3 (en) Azeotropic compositions containing octamethyltrisiloxane and n-propoxypropanol
GB9400538D0 (en) Hydrate inhibition
EP0890638A4 (en) INHIBITOR OF CANCER METASAS.
GB9621852D0 (en) Inhibition of scale
ZA96725B (en) Use of phenyclyclohexylcarboxamides
EP0806950A4 (en) METHOD FOR INHIBITING ENVIRONMENTALLY DRUGS
EP0833668A4 (en) INHIBITATION OF THE HEPATITIS B VIRUS REPLICATION
GB9509944D0 (en) Toiletries composition